Exo Therapeutics
is a Massachusetts-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer... Read moreExo Therapeutics
is a Massachusetts-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer... Read more
News
Nov 18, 2024
Business Wire
Press Release: Exo Therapeutics : Exo Therapeutics Presents Data on Novel Exosite Inhibitors of TBK1 (EXO-TBKi) Shown to Disrupt Pathological STING-mediated TBK1 Activation at American College of Rheumatology's Convergence (ACR)
Jun 20, 2024
Business Wire
Press Release: Exo Therapeutics : Exo Therapeutics Presents Key Data at FOCIS 2024 Demonstrating the Efficacy of Potent and Selective Exosite-targeted TBK1/STING Inhibitor in Multiple Preclinical Models
May 23, 2023
Business Wire
Press Release: Exo Therapeutics : Exo Announces Lead Program, Targeting TANK Binding Kinase 1 (TBK1), for the Treatment of Autoimmune Diseases
Jan 04, 2023
Business Wire
Press Release: Exo Therapeutics : Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair
Apr 27, 2022
Citybizlist
Exo Therapeutics: Exo Therapeutics Appoints Laura Kiessling to Scientific Advisory Board
Oct 06, 2021
Global University Venturing
Exo Therapeutics: Exo Therapeutics bags $78m - University Venturing: News, Data, and Events - Global University Venturing
Oct 05, 2021
The Business Journals
Exo Therapeutics: Novartis-backed biotech startup raises $78M
Oct 05, 2021
MedCity News
Exo Therapeutics: Exo Therapeutics adds $78M as cancer, inflammation drugs march toward clinic
Dec 16, 2020
Boston Citybizlist
Exo Therapeutics: Exo Therapeutics Launches with $25 Million Series A Financing
